ISSN: 1109-6535

Journal Home

Journal Guideline

Cancer Genomics and Proteomics Q2 Unclaimed

International Institute of Anticancer Research Greece

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Genomics and Proteomics is a journal indexed in SJR in Molecular Biology and Medicine (miscellaneous) with an H index of 50. It has an SJR impact factor of 0,722 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,722.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Biochemistry (Q2) Genetics (Q2) Medicine (miscellaneous) (Q2) Cancer Research (Q3) Molecular Biology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,722

SJR Impact factor

50

H Index

65

Total Docs (Last Year)

197

Total Docs (3 years)

4039

Total Refs

516

Total Cites (3 years)

197

Citable Docs (3 years)

2.8

Cites/Doc (2 years)

62.14

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Molecular Brain Q2
Frontiers in Molecular Neuroscience Q2
Mitochondrion Q2
Developmental Biology Q2
Advances in Biological Regulation Q2

Compare this journals

Aims and Scope

Best articles by citations

Indirect Down-regulation of Tumor-suppressive let-7 Family MicroRNAs by LMO1 in Neuroblastoma

Human Periprostatic Adipose Tissue: Secretome from Patients With Prostate Cancer or Benign Prostate Hyperplasia

Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome

Regulation of REG4 Expression and Prediction of 5-Fluorouracil Sensitivity by CDX2 in Ovarian Mucinous Carcinoma

A Comprehensive Method for Detecting Fusion Genes in Paediatric Brain Tumours

KIF15 Expression in Tumor-associated Monocytes Is a Prognostic Biomarker in Hepatocellular Carcinoma

Diagnosis of Non-small Cell Lung Cancer for Early Stage Asymptomatic Patients

Pathogenic and Targetable Genetic Alterations in Resected Recurrent Undifferentiated Pleomorphic Sarcomas Identified by Targeted Next-generation Sequencing

Stratification Using hTERT and Stem Cell Markers Confers a Good Prognosis in Invasive Breast Cancer

Intracellular Chloride Ion Channel Protein-1 Expression in Clear Cell Renal Cell Carcinoma

NOTUM Is Involved in the Progression of Colorectal Cancer

Gene Expression Profiles Induced by High-dose Ionizing Radiation in MDA-MB-231 Triple-negative Breast Cancer Cell Line

SHOW MORE ARTICLES

Genetic Association Analysis of Cell Cycle Regulators Reveals YWHAZ Has Prognostic Significance in Prostate Cancer

MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance

Fusion of the COL1A1 and FYN Genes in Epithelioid Osteoblastoma

Fusion of the Genes PHF1 and TFE3 in Malignant Chondroid Syringoma

Fusion of the Genes WWTR1 and FOSB in Pseudomyogenic Hemangioendothelioma

Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer

Significant Association Between the MiR146a Genotypes and Susceptibility to Childhood Acute Lymphoblastic Leukemia in Taiwan

Proteomics-based Predictive Model for the Early Detection of Metastasis and Recurrence in Head and Neck Cancer

A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pancreatic Cancer

A Novel Anionic-phosphate-platinum Complex Effectively Targets a Cisplatinum-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse Model

BRD4-Regulated Molecular Targets in Mantle Cell Lymphoma: Insights into Targeted Therapeutic Approach

EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors